Similarly, given the significant effects of G-CSF on progenitor cells, more detailed experiments addressing the effects of G-CSF administration on mobilization of stem cells subsets such as mesenchymal stem cells (MSCs) or very small embryonic-like stem cells (VSELs) in MD patients would be of significant interest. The gene discussed is CSF3; the disease is Menkes disease.